Takahiro Kochi Selected Research

Liver Neoplasms (Liver Cancer)

8/2017	Preventive effects of the sodium glucose cotransporter 2 inhibitor tofogliflozin on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic mice.
3/2016	Preventive effects of astaxanthin on diethylnitrosamine-induced liver tumorigenesis in C57/BL/KsJ-db/db obese mice.
3/2015	Chemopreventive potential of green tea catechins in hepatocellular carcinoma.
6/2011	Pitavastatin suppresses diethylnitrosamine-induced liver preneoplasms in male C57BL/KsJ-db/db obese mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takahiro Kochi Research Topics

Disease

22	Carcinogenesis 01/2021 - 06/2011
18	Inflammation (Inflammations) 01/2023 - 06/2011
14	Neoplasms (Cancer) 05/2022 - 01/2013
10	Hepatocellular Carcinoma (Hepatoma) 12/2022 - 10/2012
9	Body Weight (Weight, Body) 02/2017 - 06/2011
8	Obesity 08/2017 - 06/2011
7	Pain (Aches) 04/2024 - 01/2019
4	Hypersensitivity (Allergy) 01/2023 - 01/2019
4	Alcoholic Fatty Liver 09/2018 - 12/2015
4	Liver Neoplasms (Liver Cancer) 08/2017 - 06/2011
4	Non-alcoholic Fatty Liver Disease 08/2017 - 01/2013
3	Neuralgia (Stump Neuralgia) 12/2021 - 01/2019
3	Colitis 01/2021 - 08/2014
3	Liver Cirrhosis (Hepatic Cirrhosis) 12/2017 - 12/2012
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2017 - 07/2013
3	Insulin Resistance 01/2015 - 07/2013
3	Aberrant Crypt Foci 12/2014 - 06/2011
2	Trigeminal Nerve Diseases (Trigeminal Nerve Disorders) 01/2024 - 04/2021
2	Trigeminal Nerve Injuries 01/2022 - 04/2021
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 09/2018
2	Fatty Liver 09/2017 - 06/2011
2	Adenocarcinoma 02/2016 - 08/2014
2	Dyslipidemias (Dyslipidemia) 01/2014 - 07/2013
2	Fibrosis (Cirrhosis) 01/2013 - 01/2013
1	Hematoma 04/2024
1	Hemorrhage 04/2024
1	Hyperalgesia 11/2022
1	Muscle Cramp (Cramp) 10/2022
1	Neurogenic Inflammation 01/2022
1	Chronic Pain 04/2021
1	Disease Progression 04/2021
1	Fistula 04/2021
1	Anemia 10/2020
1	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 10/2020

Drug/Important Bio-Agent (IBA)

6	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 08/2017 - 06/2011
6	AzoxymethaneIBA 02/2017 - 07/2013
5	Drinking WaterIBA 02/2017 - 06/2011
4	Proteins (Proteins, Gene)FDA Link 08/2017 - 06/2011
4	AdipokinesIBA 03/2016 - 06/2011
4	Messenger RNA (mRNA)IBA 03/2016 - 01/2013
3	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2023 - 10/2012
3	HMGB1 Protein (HMG1)IBA 01/2022 - 01/2019
3	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2021 - 01/2013
3	AntioxidantsIBA 03/2016 - 01/2013
3	sodium sulfate (sodium bisulfate)FDA LinkGeneric 02/2016 - 01/2014
3	Dextrans (Dextran)FDA Link 02/2016 - 01/2014
3	TeaIBA 01/2016 - 01/2013
3	CateninsIBA 12/2014 - 06/2011
3	3,7,11,15- tetramethyl- 2,4,6,10,14- hexadecapentaenoic acidIBA 01/2014 - 10/2012
2	Monoclonal AntibodiesIBA 01/2024 - 04/2021
2	CalciumIBA 01/2023 - 01/2022
2	Bevacizumab (Avastin)FDA Link 12/2022 - 01/2014
2	mirogabalinIBA 01/2022 - 04/2021
2	Sorafenib (BAY 43-9006)FDA Link 04/2021 - 04/2015
2	Pentoxifylline (Trental)FDA LinkGeneric 09/2018 - 05/2016
2	Branched-Chain Amino AcidsIBA 12/2017 - 12/2012
2	CarcinogensIBA 02/2017 - 01/2013
2	clobenpropitIBA 01/2017 - 02/2016
2	Cimetidine (Biomet)FDA LinkGeneric 01/2017 - 02/2016
2	AdiponectinIBA 03/2016 - 06/2011
2	Sodium Glutamate (Accent)IBA 03/2016 - 12/2015
2	astaxanthine (astaxanthin)IBA 03/2016 - 12/2014
2	CytokinesIBA 08/2014 - 07/2014
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2014 - 06/2011
2	Captopril (Capoten)FDA LinkGeneric 07/2014 - 06/2011
1	1,1,1,3,3,3- hexafluoro- 2- (2- fluoro- 4'- ((4- (pyridin- 4- ylmethyl)piperazin- 1- yl)methyl)- (1,1'- biphenyl)- 4- yl)propan- 2- olIBA 01/2023
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2023
1	acarboxyprothrombin (PIVKA)IBA 12/2022
1	atezolizumabIBA 12/2022
1	Macrophage Colony-Stimulating FactorIBA 11/2022
1	pexidartinibIBA 11/2022
1	SaporinsIBA 11/2022
1	Valproic Acid (Depakote)FDA LinkGeneric 11/2022
1	ORALIT (ORS)IBA 10/2022
1	Biomarkers (Surrogate Marker)IBA 10/2022
1	SERPIN-B5 (maspin)IBA 05/2022
1	Pentobarbital (Nembutal)FDA Link 01/2022
1	Substance PIBA 01/2022
1	AlarminsIBA 04/2021
1	AcetoneIBA 04/2021
1	lenvatinibIBA 04/2021
1	Tyrosine Kinase InhibitorsIBA 04/2021
1	Dinoprostone (PGE2)FDA Link 01/2021
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2019
1	Toll-Like Receptor 4IBA 01/2019
1	Toll-Like Receptor 5IBA 01/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019
1	Neutralizing AntibodiesIBA 01/2019
1	CXC ChemokinesIBA 01/2019

Therapy/Procedure

10	Chemoprevention 01/2021 - 06/2011
6	Subcutaneous Injections 09/2017 - 06/2011
4	Intraperitoneal Injections 01/2022 - 01/2013
3	Therapeutics 05/2022 - 01/2016
1	Punctures 04/2024
1	Spinal Injections 11/2022
1	Injections 01/2022
1	Surgical Instruments (Clip) 04/2021
1	Liver Transplantation 10/2020
1	Ligation 01/2019